This outcome provides strong support for the potential of LD2-LD4 as a promising therapeutic approach against cancer, thus raising the possibility for the design and generation of effective small-molecule dual FAK/PYK2 inhibitors to prevent metastasis. This evidence concerns the gene PTK2B and cancer.